Down regulation or loss of SULT1E1 could be to a certain extent responsible for growth of tumor in hormone sensitive cancers such as breast or endometrial cancer (Cole et al., 2010)
Theanine c bit l c nh hng n hot ng dopaminergic v serotonergic
Overall, tirzepatides dual agonism of GLP1 and GIP receptors appears to provide encouraging cardiovascular benefits beyond glycemic control, offering a potential new therapeutic option for treating cardiovascular diseases and heart failure
Results Disclaimer: Individual results from GLP-1 weight loss treatment vary based on factors including age, baseline health condition, metabolic profile, consistency of use, dietary habits, physical activity levels, genetic factors, and adherence to clinical guidance
Supporting your wellness is your personal business
Chalcone synthase and its functions in plant resistance